Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹655 Cr
down ₹18.6 Cr vs Jan 2023
- Stocks held
- 32
- unchanged
- Top 10 weight
- 59.1%
- of the portfolio in its ten largest
- Cash & debt
- 1.5%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 19
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In February 2023 it disclosed 32 stocks worth ₹655 Cr, down ₹18.6 Cr from Jan 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.1%), Cipla Limited (7.6%), Dr. Reddy's Laboratories Limited (7.0%); the ten largest together made up 59.1% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.8% of its equity. Cash and debt stood at 1.5%. Compared with Jan 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
81%
Top-10 weight is higher than 81% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
23%
Holds more cash than 23% of peers
Holdings in February 2023
Download CSVEvery line the fund disclosed, with the change against Jan 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.15%
- Δ weight
- down 0.87 pts
- Value
- ₹86.1 Cr
- Δ value
- down ₹8.3 Cr
- Status
- Trimmed
- Weight
- 7.60%
- Δ weight
- down 0.70 pts
- Value
- ₹49.8 Cr
- Δ value
- down ₹6.1 Cr
- Status
- Trimmed
- Weight
- 6.98%
- Δ weight
- up 0.02 pts
- Value
- ₹45.8 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 6.72%
- Δ weight
- up 0.40 pts
- Value
- ₹44 Cr
- Δ value
- up ₹1.5 Cr
- Status
- Added
- Weight
- 4.51%
- Δ weight
- down 0.22 pts
- Value
- ₹29.6 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
- Weight
- 4.31%
- Δ weight
- up 0.32 pts
- Value
- ₹28.2 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 4.22%
- Δ weight
- up 0.13 pts
- Value
- ₹27.7 Cr
- Δ value
- up ₹9 L
- Status
- Held
- Weight
- 4.13%
- Δ weight
- up 0.59 pts
- Value
- ₹27 Cr
- Δ value
- up ₹3.2 Cr
- Status
- Added
- Weight
- 3.77%
- Δ weight
- down 0.34 pts
- Value
- ₹24.7 Cr
- Δ value
- down ₹3 Cr
- Status
- Trimmed
- Weight
- 3.70%
- Δ weight
- down 0.08 pts
- Value
- ₹24.2 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Trimmed
- Weight
- 3.54%
- Δ weight
- up <0.01 pts
- Value
- ₹23.2 Cr
- Δ value
- down ₹66 L
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- down 0.46 pts
- Value
- ₹21.2 Cr
- Δ value
- down ₹3.7 Cr
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- up <0.01 pts
- Value
- ₹21.2 Cr
- Δ value
- down ₹58 L
- Status
- Trimmed
- Weight
- 3.05%
- Δ weight
- down 0.04 pts
- Value
- ₹20 Cr
- Δ value
- down ₹85 L
- Status
- Trimmed
- Weight
- 2.69%
- Δ weight
- up 0.59 pts
- Value
- ₹17.6 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 2.18%
- Δ weight
- down 0.05 pts
- Value
- ₹14.3 Cr
- Δ value
- down ₹74 L
- Status
- Trimmed
- Weight
- 2.07%
- Δ weight
- down 0.35 pts
- Value
- ₹13.5 Cr
- Δ value
- down ₹2.8 Cr
- Status
- Trimmed
- Weight
- 1.98%
- Δ weight
- up <0.01 pts
- Value
- ₹13 Cr
- Δ value
- down ₹34 L
- Status
- Trimmed
- Weight
- 1.97%
- Δ weight
- up 0.29 pts
- Value
- ₹12.9 Cr
- Δ value
- up ₹1.6 Cr
- Status
- Added
- Weight
- 1.96%
- Δ weight
- up 0.14 pts
- Value
- ₹12.8 Cr
- Δ value
- up ₹57 L
- Status
- Added
- Weight
- 1.78%
- Δ weight
- down 0.17 pts
- Value
- ₹11.7 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 1.63%
- Δ weight
- up 0.07 pts
- Value
- ₹10.7 Cr
- Δ value
- up ₹16 L
- Status
- Added
- Weight
- 1.38%
- Δ weight
- up 0.80 pts
- Value
- ₹9.1 Cr
- Δ value
- up ₹5.1 Cr
- Status
- Added
- Weight
- 1.34%
- Δ weight
- down 0.09 pts
- Value
- ₹8.8 Cr
- Δ value
- down ₹87 L
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 1.32%
- Δ weight
- down 0.40 pts
- Value
- ₹8.6 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 1.15%
- Δ weight
- up 0.13 pts
- Value
- ₹7.6 Cr
- Δ value
- up ₹66 L
- Status
- Added
- Weight
- 1.15%
- Δ weight
- up 0.38 pts
- Value
- ₹7.5 Cr
- Δ value
- up ₹2.3 Cr
- Status
- Added
- Weight
- 1.08%
- Δ weight
- up 0.06 pts
- Value
- ₹7.1 Cr
- Δ value
- up ₹20 L
- Status
- Added
- Weight
- 0.94%
- Δ weight
- up 0.14 pts
- Value
- ₹6.1 Cr
- Δ value
- up ₹75 L
- Status
- Added
- Weight
- 0.86%
- Δ weight
- down 0.07 pts
- Value
- ₹5.6 Cr
- Δ value
- down ₹66 L
- Status
- Trimmed
- Weight
- 0.81%
- Δ weight
- up 0.01 pts
- Value
- ₹5.3 Cr
- Δ value
- down ₹10 L
- Status
- Trimmed
- Weight
- 0.80%
- Δ weight
- down 0.10 pts
- Value
- ₹5.3 Cr
- Δ value
- down ₹83 L
- Status
- Trimmed
- Weight
- 0.59%
- Δ weight
- down 0.13 pts
- Value
- ₹3.9 Cr
- Δ value
- down ₹100 L
- Status
- Trimmed
- 364 D TBILL MATDebt
- Weight
- 0.20%
- Δ weight
- up 0.01 pts
- Value
- ₹1.3 Cr
- Δ value
- up ₹1 L
- Status
- Held
What changed, Jan 2023 to Feb 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Syngene International Limitedup ₹5.1 Cr (+0.80% pts)
- Gland Pharma Limitedup ₹3.5 Cr (+0.59% pts)
- Aurobindo Pharma Limitedup ₹3.2 Cr (+0.59% pts)
- Sanofi India Limitedup ₹2.3 Cr (+0.38% pts)
- Procter & Gamble Health Limitedup ₹1.6 Cr (+0.29% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jan 2023, the weight rose most in Healthcare Services (+0.5 pts) and Healthcare Equipment & Supplies (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−0.7 pts).
- Healthcare Services19.5% → 20.0%+0.5 pts
- Healthcare Equipment & Supplies1.9% → 2.0%+0.1 pts
- Pharmaceuticals1.0% → 1.2%+0.1 pts
- Pharmaceuticals & Biotechnology77.6% → 76.8%−0.7 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Feb 2020 | Feb 2022 | Jul 2022 | Nov 2022 | Jan 2023 | Feb 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 85.7% | 79.9% | 79.8% | 77.7% | 77.6% | 76.8% |
| Healthcare Services | 13.2% | 17.0% | 17.1% | 19.2% | 19.5% | 20.0% |
| Healthcare Equipment & Supplies | — | 1.6% | 1.6% | 1.8% | 1.9% | 2.0% |
| Pharmaceuticals | — | — | 0.7% | 1.3% | 1.0% | 1.2% |
Allocation in Feb 2023change vs Jan 2023
- Pharmaceuticals & Biotechnology (24)76.8%▼ 0.7 pts
- Healthcare Services (6)20.0%▲ 0.5 pts
- Healthcare Equipment & Supplies (1)2.0%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Feb 2023
1.5%
▼ 0.4 pts vs Jan 2023
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 2.7%
- Feb 2022 · now ▼ 1.2 pts
- Last 12 months
- 1.4% – 3.3%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.